Live Breaking News & Updates on Disease Recurrence

Stay updated with breaking news from Disease recurrence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oncotype Score Helps Avoid Unnecessary Radiation in DCIS

Using a gene test to guide radiation decisions may reduce overtreatment in ductal carcinoma in situ. ....

Northwestern-university , Illinois , United-states , Chicago , San-antonio , Texas , Seema-khan , Ut-health-san-antonio , Antonio-breast-cancer , Breast-cancer , Alignant-breast-neoplasm , Breast-carcinoma

Pilonidal Disease: Study Finds Laser Hair Removal Beneficial

The study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease. ....

Facial-rejuvenation , Aesthetic-medicine , Skin-and-soft-tissue-infection , Laser-hair-removal , Aser-assisted-hair-removal , Pilonidal-disease , Laser , Hair , Surgery , Disease-recurrence , Adherence

Syndax Announces Updated Data Supporting Impressive Clinical Profile of Revumenib in Genetically-Defined Acute Leukemias to Be Presented at the 65th ASH Annual Meeting

WALTHAM - Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that updated data from multiple trials across its. ....

San-diego , California , United-states , American , Andrius-zuenka , Ghayas-issa , Revumenib-monotherapy , Decitabine-cedazuridine , Sharon-klahre , Michaela-metzger , Ibrahim-aldoss , Drug-administration

FDA Approves Nivolumab for Resected Stage IIB/C Melanoma

The new approval expands the melanoma indication for nivolumab to earlier-stage disease. ....

Bristol-myers-squibb , Drug-administration , Myers-squibb , Melanoma , Malignant-melanoma , Skin-cancer , Alignant-skin-neoplasm , Disease-recurrence , Sentinel-lymph-node , Toxicology , Alabama , Children

Pinpointing Key Features of Gut Dysbiosis in Melanoma

Fecal microbiota profiles differ among patients with melanoma and those without as well as between patients with early stage and late-stage disease, new data suggest. ....

Houston , Texas , United-states , Russell-witt , Bristol-myers-squibb , Md-anderson-cancer-center , Novartis , National-institutes-of-health , Cancer-center , National-institutes , Melanoma , Malignant-melanoma